Piper Sandler Maintains Neutral on Alpha Tau Medical, Raises Price Target to $8

Piper Sandler analyst Jason Bednar maintains Alpha Tau Medical (NASDAQ:DRTS) with a Neutral and raises the price target from $5 to $8.